Top

Quality of Life Research

Gepubliceerd in:

13-09-2020

Randomized Clinical Trial on Reduction of Radiotherapy Dose to the Elective Neck in Head and Neck Squamous Cell Carcinoma: Results on the Quality of Life

Auteurs: S. Deschuymer, D. Nevens, F. Duprez, J. F. Daisne, M. Voordeckers, W. De Neve, S. Nuyts

Gepubliceerd in: Quality of Life Research | Uitgave 1/2021

Abstract

Purpose

A randomized trial was initiated to investigate whether a reduction of the dose to the elective nodal sites would result in less toxicity and improvement in Quality of Life (QoL) without compromising tumor control. This paper aimed to compare QoL in both treatment arms.

Methods

Two-hundred head and neck cancer patients treated with radiotherapy (RT) or chemo-RT were randomized (all stages, mean age: 60 years, M/F: 82%/18%). The elective nodal volumes of patients randomized in the experimental arm were treated up to a 40 Gy equivalent dose. In the standard arm, the elective nodal volumes were treated up to a 50 Gy equivalent dose. The QoL data were collected using The European Organization for Research and Treatment of Cancer (EORTC) core questionnaire QLQ-C30 and the EORTC Head and Neck Cancer module (H&N35).

Results

A trend toward less decline in QoL during treatment was observed in the 40 Gy arm compared to the 50 Gy arm. Statistically significant differences for global health status, physical functioning, emotional functioning, speech problems, and trouble with social eating in favor of the 40 Gy arm were observed. A clinically relevant better outcome in the 40 Gy arm was found for physical functioning at the end of therapy.

Conclusion

QoL during RT for head and neck cancer tends to be less impaired in the 40 Gy arm. However, reducing the dose only on the elective neck does not result in clinically relevant improvement of QoL. Therefore, additional treatment strategies must be examined to further improve the QoL of HNSCC patients.

vorige artikel Changes in patient functioning and disability: results from a phase 3, double-blind, randomized, placebo-controlled clinical trial evaluating galcanezumab for chronic migraine prevention (REGAIN)

volgende artikel Predictors for quality of life improvement after acute osteoporotic vertebral fracture: results of post hoc analysis of a prospective randomized study

Alleen toegankelijk voor geautoriseerde gebruikers

Grégoire, V., Langendijk, J. A., & Nuyts, S. (2015). Advances in radiotherapy for head and neck cancer. Journal of Clinical Oncology, 33(29), 3277–3284. https://doi.org/10.1200/JCO.2015.61.2994.CrossRefPubMed

Bourhis, J., Overgaard, J., Audry, H., Ang, K. K., Saunders, M., Bernier, J., et al. (2006). Hyperfractionated or accelerated radiotherapy in head and neck cancer: A meta-analysis. The Lancet, 368(938), 843–854. https://doi.org/10.1016/S0140-6736(06)69121-6.CrossRef

Blanchard, P., Baujat, B., Holostenco, V., Bourredjem, A., Baey, C., Bourhis, J., et al., …, MACH-CH Collaborative Group. (2011). Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): A comprehensive analysis by tumour site. Radiotherapy and Oncology, 100(1), 33–40. https://doi.org/10.1016/j.radonc.2011.05.036.CrossRefPubMed

Nuyts, S., Dirix, P., Clement, P. M. J., Vander Poorten, V., Delaere, P., Schoenaers, J., et al. (2009). Impact of adding concomitant chemotherapy to hyperfractionated accelerated radiotherapy for advanced head-and-neck squamous cell carcinoma. International Journal of Radiation Oncology, Biology, Physics, 73(4), 1088–1095. https://doi.org/10.1016/j.ijrobp.2008.05.042.CrossRefPubMed

Machtay, M., Moughan, J., Trotti, A., Garden, A. S., Weber, R. S., Cooper, J. S., …, Ang, K. K. (2008). Factors associated with severe late toxicity after concurrent chemoradiation for locally advanced head and neck cancer: An RTOG analysis. Journal of Clinical Oncology, 26(21), 3582–3589. https://doi.org/10.1200/JCO.2007.14.8841.CrossRefPubMedPubMedCentral

Langendijk, J. A., Doornaert, P., Verdonck-de Leeuw, I. M., Leemans, C. R., Aaronson, N. K., & Slotman, B. J. (2008). Impact of late treatment-related toxicity on quality of life among patients with head and neck cancer treated with radiotherapy. Journal of Clinical Oncology, 26(22), 3770–3776. https://doi.org/10.1200/JCO.2007.14.6647.CrossRefPubMed

Nutting, C. M., Morden, J. P., Harrington, K. J., Urbano, T. G., Bhide, S. A., Clark, C., et al. (2011). Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): A phase 3 multicentre randomised controlled trial. The Lancet Oncology, 12(2), 127–136. https://doi.org/10.1016/S1470-2045(10)70290-4.CrossRefPubMedPubMedCentral

Langendijk, J. A., Doornaert, P., Rietveld, D. H. F., Verdonck-de Leeuw, I. M., Leemans, C. R., & Slotman, B. J. (2009). A predictive model for swallowing dysfunction after curative radiotherapy in head and neck cancer. Radiotherapy and Oncology, 90(2), 189–195. https://doi.org/10.1016/j.radonc.2008.12.017.CrossRefPubMed

Dirix, P., Abbeel, S., Vanstraelen, B., Hermans, R., & Nuyts, S. (2009). Dysphagia after chemoradiotherapy for head-and-neck squamous cell carcinoma: Dose-effect relationships for the swallowing structures. International Journal of Radiation Oncology, Biology, Physics, 75(2), 385–392. https://doi.org/10.1016/j.ijrobp.2008.11.041.CrossRefPubMed

10.

Levendag, P. C., Teguh, D. N., Voet, P., van der Est, H., Noever, I., de Kruijf, W. J. M., …, Heijmen, B. J. (2007). Dysphagia disorders in patients with cancer of the oropharynx are significantly affected by the radiation therapy dose to the superior and middle constrictor muscle: A dose-effect relationship. Radiotherapy and Oncology, 85(1), 64–73. https://doi.org/10.1016/j.radonc.2007.07.009.CrossRefPubMed

11.

Christianen, M. E. M. C., Schilstra, C., Beetz, I., Muijs, C. T., Chouvalova, O., Burlage, F. R., …, Langendijk, J. A. (2012). Predictive modelling for swallowing dysfunction after primary (chemo)radiation: Results of a prospective observational study. Radiotherapy and Oncology, 105(1), 107–114. https://doi.org/10.1016/j.radonc.2011.08.009.CrossRefPubMed

12.

Feng, F. Y., Kim, H. M., Lyden, T. H., Haxer, M. J., Worden, F. P., Feng, M., …, Eisbruch, A. (2010). Intensity-modulated chemoradiotherapy aiming to reduce dysphagia in patients with oropharyngeal cancer: clinical and functional results. Journal of Clinical Oncology, 28(16), 2732–2738. https://doi.org/10.1200/JCO.2009.24.6199.CrossRefPubMedPubMedCentral

13.

Maccomb, W. S., & Fletcher, G. H. (1957). Planned combination of surgery and radiation in treatment of advanced primary head and neck cancers. The American Journal of Roentgenology, Radium Therapy, and Nuclear Medicine, 77(3), 397–414.PubMed

14.

Nuyts, S., Lambrecht, M., Duprez, F., Daisne, J.-F., Van Gestel, D., Van den Weyngaert, D., … De Neve, W. (2013). Reduction of the dose to the elective neck in head and neck squamous cell carcinoma, a randomized clinical trial using intensity modulated radiotherapy (IMRT). Dosimetrical analysis and effect on acute toxicity. Radiotherapy and Oncology, 109(2), 323–329. https://doi.org/10.1016/j.radonc.2013.06.044

15.

Nevens, D., Duprez, F., Daisne, J. F., Dok, R., Belmans, A., Voordeckers, M., … Nuyts, S. (2017). Reduction of the dose of radiotherapy to the elective neck in head and neck squamous cell carcinoma; a randomized clinical trial. Effect on late toxicity and tumor control. Radiotherapy and Oncology, 122(2), 171–177. https://doi.org/10.1016/j.radonc.2016.08.009

16.

Nevens, D., Duprez, F., Daisne, J.-F., Schatteman, J., Van der Vorst, A., De Neve, W., et al. (2017). Recurrence patterns after a decreased dose of 40Gy to the elective treated neck in head and neck cancer. Radiotherapy and Oncology, 123(3), 419–423. https://doi.org/10.1016/j.radonc.2017.03.003.CrossRefPubMed

17.

Deschuymer, S., Nevens, D., Duprez, F., Daisne, J.-F., Dok, R., Laenen, A., …, Nuyts, S. (2020). Randomized clinical trial on reduction of radiotherapy dose to the elective neck in head and neck squamous cell carcinoma; update of the long-term tumor outcome. Radiotherapy and Oncology, 143, 24–29. https://doi.org/10.1016/j.radonc.2020.01.005.CrossRefPubMed

18.

Grégoire, V., Eisbruch, A., Hamoir, M., & Levendag, P. (2006). Proposal for the delineation of the nodal CTV in the node-positive and the post-operative neck. Radiotherapy and Oncology, 79(1), 15–20. https://doi.org/10.1016/j.radonc.2006.03.009.CrossRefPubMed

19.

Aaronson, N. K., Ahmedzai, S., Bergman, B., Bullinger, M., Cull, A., Duez, N. J., …, de Haes, J. C. (1993). The European Organization for Research and Treatment of Cancer QLQ-C30: A quality-of-life instrument for use in international clinical trials in oncology. Journal of the National Cancer Institute, 85(5), 365–376.CrossRef

20.

Bjordal, K., Hammerlid, E., Ahlner-Elmqvist, M., de Graeff, A., Boysen, M., Evensen, J. F., …, Kaasa, S. (1999). Quality of life in head and neck cancer patients: Validation of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-H&N35. Journal of Clinical Oncology, 17(3), 1008–1019. https://doi.org/10.1200/JCO.1999.17.3.1008.CrossRefPubMed

21.

Singer, S., Wollbrück, D., Wulke, C., Dietz, A., Klemm, E., Oeken, J., …, Schwarz, R. (2009). Validation of the EORTC QLQ-C30 and EORTC QLQ-H&N35 in patients with laryngeal cancer after surgery. Head & Neck, 31(1), 64–76. https://doi.org/10.1002/hed.20938.CrossRef

22.

Singer, S., Arraras, J. I., Chie, W.-C., Fisher, S. E., Galalae, R., Hammerlid, E., …, Hofmeister, D. (2013). Performance of the EORTC questionnaire for the assessment of quality of life in head and neck cancer patients EORTC QLQ-H&N35: A methodological review. Quality of Life Research, 22(8), 1927–1941. https://doi.org/10.1007/s11136-012-0325-1.CrossRefPubMed

23.

Fayers, P. M., Aaronson, N. K., Bjordal, K., Groenvold, M., Curran, D., Bottomley, A. & On behalf of the EORTC Quality of Life Group. (2001). The EORTC QLQ-C30 Scoring Manual (3rd Edition). Brussels: European Organisation for Research and Treatment of Cancer.

24.

Cocks, K., King, M. T., Velikova, G., Martyn St-James, M., Fayers, P. M., & Brown, J. M. (2011). Evidence-based guidelines for determination of sample size and interpretation of the European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire Core 30. Journal of Clinical Oncology, 29(1), 89–96. https://doi.org/10.1200/JCO.2010.28.0107.CrossRefPubMed

25.

Osoba, D., Rodrigues, G., Myles, J., Zee, B., & Pater, J. (1998). Interpreting the significance of changes in health-related quality-of-life scores. Journal of Clinical Oncology, 16(1), 139–144. https://doi.org/10.1200/JCO.1998.16.1.139.CrossRefPubMed

26.

Scott, N. W., Fayers, P. M., Aaronson, N. K., Bottomley, A., Graeff, A., Groenvold, M., Gundy, C., Koller, M., Petersen, M. A., Mirjam A. G., & Sprangers on behalf of the EORTC Quality of Life Group. (2008). EORTC QLQ-C30 Reference values manual. Brussels. EORTC Quality of Life Group Publications.

27.

Bottomley, A., Tridello, G., Coens, C., Rolland, F., Tesselaar, M. E. T., Leemans, C. R., …, Lefebvre, J.-L. (2014). An international phase 3 trial in head and neck cancer: quality of life and symptom results: EORTC 24954 on behalf of the EORTC Head and Neck and the EORTC Radiation Oncology Group. Cancer, 120(3), 390–398. https://doi.org/10.1002/cncr.28392.CrossRefPubMed

28.

de Graeff, A., de Leeuw, J. R., Ros, W. J., Hordijk, G. J., Blijham, G. H., & Winnubst, J. A. (2000). Long-term quality of life of patients with head and neck cancer. The Laryngoscope, 110(1), 98–106. https://doi.org/10.1097/00005537-200001000-00018.CrossRefPubMed

29.

Curran, D., Giralt, J., Harari, P. M., Ang, K. K., Cohen, R. B., Kies, M. S., …, Bonner, J. A. (2007). Quality of life in head and neck cancer patients after treatment with high-dose radiotherapy alone or in combination with cetuximab. Journal of Clinical Oncology, 25(16), 2191–2197. https://doi.org/10.1200/JCO.2006.08.8005.CrossRefPubMed

30.

Vainshtein, J. M., Moon, D. H., Feng, F. Y., Chepeha, D. B., Eisbruch, A., & Stenmark, M. H. (2015). Long-term quality of life after swallowing and salivary-sparing chemo-intensity modulated radiation therapy in survivors of human papillomavirus-related oropharyngeal cancer. International Journal of Radiation Oncology, Biology, Physics, 91(5), 925–933. https://doi.org/10.1016/j.ijrobp.2014.12.045.CrossRefPubMedPubMedCentral

31.

Meirovitz, A., Murdoch-Kinch, C. A., Schipper, M., Pan, C., & Eisbruch, A. (2006). Grading xerostomia by physicians or by patients after intensity-modulated radiotherapy of head-and-neck cancer. International Journal of Radiation Oncology, Biology, Physics, 66(2), 445–453. https://doi.org/10.1016/j.ijrobp.2006.05.002.CrossRefPubMed

32.

Kaae, J. K., Johnsen, L., Hansen, C. R., Kristensen, M. H., Brink, C., & Eriksen, J. G. (2019). Relationship between patient and physician-rated xerostomia and dose distribution to the oral cavity and salivary glands for head and neck cancer patients after radiotherapy. Acta oncologica (Stockholm, Sweden), 58(10), 1366–1372. https://doi.org/10.1080/0284186X.2019.1627413.CrossRef

33.

de Veij Mestdagh, P. D., Jonker, M. C. J., Vogel, W. V., Schreuder, W. H., Donswijk, M. L., Klop, W. M. C., et al. (2018). SPECT/CT-guided lymph drainage mapping for the planning of unilateral elective nodal irradiation in head and neck squamous cell carcinoma. European Archives of Oto-Rhino-Laryngology, 275(8), 2135–2144. https://doi.org/10.1007/s00405-018-5050-0.CrossRefPubMed

34.

de Veij Mestdagh, P. D., Schreuder, W. H., Vogel, W. V., Donswijk, M. L., van Werkhoven, E., van der Wal, J. E., …, Al-Mamgani, A. (2019). Mapping of sentinel lymph node drainage using SPECT/CT to tailor elective nodal irradiation in head and neck cancer patients (SUSPECT-2): A single-center prospective trial. BMC Cancer, 19(1), 1110. https://doi.org/10.1186/s12885-019-6331-8.CrossRefPubMedPubMedCentral

35.

Daisne, J.-F., Installé, J., Bihin, B., Laloux, M., Vander Borght, T., Mathieu, I., et al. (2014). SPECT/CT lymphoscintigraphy of sentinel node(s) for superselective prophylactic irradiation of the neck in cN0 head and neck cancer patients: A prospective phase I feasibility study. Radiation Oncology, 9, 121. https://doi.org/10.1186/1748-717X-9-121.CrossRefPubMed

36.

Blanchard, P., Garden, A. S., Gunn, G. B., Rosenthal, D. I., Morrison, W. H., Hernandez, M., …, Frank, S. J. (2016). Intensity-modulated proton beam therapy (IMPT) versus intensity-modulated photon therapy (IMRT) for patients with oropharynx cancer—a case matched analysis. Radiotherapy and Oncology, 120(1), 48–55. https://doi.org/10.1016/j.radonc.2016.05.022.CrossRefPubMedPubMedCentral

37.

Bottomley, A., Flechtner, H., Efficace, F., Vanvoorden, V., Coens, C., Therasse, P., et al. (2005). Health related quality of life outcomes in cancer clinical trials. European Journal of Cancer, 41(12), 1697–1709. https://doi.org/10.1016/j.ejca.2005.05.007.CrossRefPubMed

38.

Bottomley, A., Pe, M., Sloan, J., Basch, E., Bonnetain, F., Calvert, M., et al., …, Setting International Standards in Analyzing Patient-Reported Outcomes and Quality of Life Endpoints Data (SISAQOL) consortium. (2016). Analysing data from patient-reported outcome and quality of life endpoints for cancer clinical trials: A start in setting international standards. The Lancet Oncology, 17(11), e510–e514. https://doi.org/10.1016/S1470-2045(16)30510-1.CrossRefPubMed

39.

Pe, M., Dorme, L., Coens, C., Basch, E., Calvert, M., Campbell, A., Campbell, A., …, Setting International Standards in Analyzing Patient-Reported Outcomes and Quality of Life Endpoints Data Consortium (SISAQOL). (2018). Statistical analysis of patient-reported outcome data in randomised controlled trials of locally advanced and metastatic breast cancer: A systematic review. The Lancet Oncology, 19(9), e459–e469. https://doi.org/10.1016/S1470-2045(18)30418-2.CrossRefPubMed

40.

Bottomley, A., Pe, M., Sloan, J., Basch, E., Bonnetain, F., Calvert, M., …, Coens, C. (2018). Moving forward toward standardizing analysis of quality of life data in randomized cancer clinical trials. Clinical Trials, 15(6), 624–630. https://doi.org/10.1177/1740774518795637.CrossRefPubMed

Titel: Randomized Clinical Trial on Reduction of Radiotherapy Dose to the Elective Neck in Head and Neck Squamous Cell Carcinoma: Results on the Quality of Life
Auteurs: S. Deschuymer
D. Nevens
F. Duprez
J. F. Daisne
M. Voordeckers
W. De Neve
S. Nuyts
Publicatiedatum: 13-09-2020
Uitgeverij: Springer International Publishing
Gepubliceerd in: Quality of Life Research / Uitgave 1/2021
Print ISSN: 0962-9343
Elektronisch ISSN: 1573-2649
DOI: https://doi.org/10.1007/s11136-020-02628-w

Bohn Stafleu van Loghum

Deel dit onderdeel of sectie (kopieer de link)

Abstract

Purpose

Methods

Results

Conclusion

Log in om toegang te krijgen

Andere artikelen Uitgave 1/2021

Quality of life in parents of seriously Ill/injured children: a prospective longitudinal study

Belief in a just world, health-related quality of life, and mental health among Chinese patients with chronic obstructive pulmonary disease

International guidance on the selection of patient-reported outcome measures in clinical trials: a review

Trajectories of health-related quality of life among people with a physical disability and/or chronic disease during and after rehabilitation: a longitudinal cohort study

Do reminder emails and past due notifications improve patient completion and institutional data submission for patient-reported outcome measures?

Fulfillment of patients’ information needs during oral cancer treatment and its association with posttherapeutic quality of life